生物活性玻璃
模拟体液
材料科学
扫描电子显微镜
微观结构
多孔性
烧结
化学工程
粒径
傅里叶变换红外光谱
无定形固体
煅烧
磷灰石
组织工程
复合材料
生物医学工程
化学
有机化学
医学
工程类
催化作用
作者
Auday A. Mehatlaf,Saad B. H. Farid,Alaa Abdulhasan Atiyah
出处
期刊:IOP conference series
[IOP Publishing]
日期:2021-02-01
卷期号:1067 (1): 012136-012136
被引量:3
标识
DOI:10.1088/1757-899x/1067/1/012136
摘要
Abstract A modified sol-gel method was used in the current work to prepare a 13-93 bioactive glass powder, which was selected for the therapeutic actions of its constituent parts. In particular bioactive glass 13-93 can chemically bond with host tissue and induce osteogenesis. The produced gel was calcined at a temperature of 600 °C, while particle size analysis and x-ray diffraction were performed after the preparation of the glass powder. Porous bioactive glass 13-93 scaffolds were synthesised using the polymer foam replication technique that uses polyurethane sponges as a template. Sintering at 700 °C was then performed for one hour to the produce the required structures. After sintering, the microstructure was examined by scanning electron microscope (SEM) and Fourier transform infrared analysis (FTIR). The x-ray diffraction (XRD) results were also examined. The average particle size of bioactive glass 13-93 thus produced was about 2.978 μm, and XRD pattern analysis showed that the porous scaffolds were amorphous. The microstructure of the 13 – 93 glass scaffolds contained interconnected cellular pores and a dense network of bioactive glass, allowing scaffolds with porosity between 80 and 83% to be obtained. An in vitro bioactivity test was performed on the scaffolds by soaking them in a solution of simulated body fluid (SBF). The subsequent SEM images confirmed the bioactivity of the prepared scaffolds based on the formation of obvious and dense hydroxyapatite particles on the surface after 7 days of immersion in SBF. It was thus concluded that bioactive glass scaffold prepared in this work via the polymer foam replication technique has the potential to be used in several future applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI